Cipher Pharmaceuticals Inc
TSX:CPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
CA |
|
Dave Inc
NASDAQ:DAVE
|
US |
|
Magellan Aerospace Corp
TSX:MAL
|
CA |
|
O
|
OpGen Inc
F:6502
|
US |
|
A
|
Alcoa Corp
F:185
|
US |
|
C
|
CenterPoint Energy Inc
F:HOU
|
US |
|
S
|
Suncor Energy Inc
DUS:SM3
|
CA |
|
China Renaissance Holdings Ltd
OTC:CSCHF
|
CN |
|
C
|
Close Brothers Group PLC
F:CS3
|
UK |
Wall St Price Targets
CPH Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for CPH is 20.22 CAD with a low forecast of 17.17 CAD and a high forecast of 23.1 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CPH's stock price target?
Price Target
20.22
CAD
According to Wall Street analysts, the average 1-year price target for CPH is 20.22 CAD with a low forecast of 17.17 CAD and a high forecast of 23.1 CAD.
What is the Revenue forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 3 years is 20%.
What is the Operating Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 1 year is 31%.
What is the Pre-Tax Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
27%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 27%.
What is the Net Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 3 years is 14%.
